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 ABSTRACT 
 
Estrogen signaling is mediated by estrogen receptors (ERs), ERα and ERβ. Aberrant 
estrogen signaling is involved in breast cancer development. ERα is one of the key 
biomarkers for diagnosis and treatment of breast cancer. Unlike ERα, ERβ is still not 
introduced as a marker for diagnosis and established as a target of therapy. Numerous 
studies suggest antiproliferative effects of ERβ, however its role remains to be fully 
explored. Albeit important, ERα is not a perfect marker, and some aspects of ERα 
function are still unclear. This thesis aims to characterize distinct molecular facets of 
ER action relevant for breast cancer and provide valuable information for ER-based 
diagnosis and treatment design.  
In PAPER I, we analyzed the functionality of two common single 
nucleotide polymorphisms in the 3’ untranslated regions of ERβ, rs4986938 and 
rs928554, which have been extensively investigated for association with various 
diseases. A significant difference in allelic expression was observed for rs4986938 in 
breast tumor samples from heterozygous individuals. However, no difference in mRNA 
stability or translatability between the alleles was observed.  
In PAPER II, we provided a more comprehensive understanding of ERβ 
function independent of ERα. A global gene expression analysis in a HEK293/ERβ cell 
model identified a set of ERβ-regulated genes. Gene Ontology (GO) analysis showed 
that they are involved in cell-cell signaling, morphogenesis and cell proliferation. 
Moreover, ERβ expression resulted in a significant decrease in cell proliferation. 
In PAPER III, using the human breast cancer MCF-7/ERβ cell model, 
we demonstrated, for the first time, the binding of ERα/β heterodimers to various 
DNA-binding regions in intact chromatin.  
In PAPER IV, we investigated a potential cross-talk between estrogen 
signaling and DNA methylation by identifying their common target genes in MCF-7 
cells. Gene expression profiling identified around 150 genes regulated by both 17β-
estradiol (E2) and a hypomethylating agent 5-aza-2’-deoxycytidine. Based on GO 
analysis, CpG island prediction analysis and previously reported ER binding regions, 
we selected six genes for further analysis. We identified BTG3 and FHL2 as direct 
target genes of both pathways. However, our data did not support a direct molecular 
interplay of mediators of estrogen and epigenetic signaling at promoters of regulated 
genes. 
In PAPER V, we further explored the interactions between estrogen 
signaling and DNA methylation, with focus on DNA methyltransferases (DNMT1, 
DNMT3a and DNMT3b). E2, via ERα, up-regulated DNMT1 and down-regulated 
DNMT3a and DNMT3b mRNA expression. Furthermore, DNMT3b interacted with 
ERα. siRNA-mediated DNMT3b depletion increased the expression of two genes, 
CDKN1A and FHL2. We proposed that the molecular mechanism underlying 
regulation of FHL2 and CDKN1A gene expression involves interplay of DNMT3b and 
ERα.   
 
In conclusion, the studies presented in this thesis contribute to the knowledge of ERβ 
function, and give additional insight into the cross-talk mechanisms underlying ERα 
signaling with ERβ and with DNA methylation pathways. 
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